These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12439358

  • 1. New therapeutic choices in the management of acute congestive heart failure.
    Young JB.
    Rev Cardiovasc Med; 2001; 2 Suppl 2():S19-24. PubMed ID: 12439358
    [Abstract] [Full Text] [Related]

  • 2. Dyspnea as an end point in clinical trials of therapies for acute decompensated heart failure.
    Teerlink JR.
    Am Heart J; 2003 Feb; 145(2 Suppl):S26-33. PubMed ID: 12594449
    [No Abstract] [Full Text] [Related]

  • 3. Optimizing outcomes in the patient with acute decompensated heart failure.
    Mehra MR.
    Am Heart J; 2006 Mar; 151(3):571-9. PubMed ID: 16504617
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Current medical treatment for the exacerbation of chronic heart failure resulting in hospitalization.
    Jain P, Massie BM, Gattis WA, Klein L, Gheorghiade M.
    Am Heart J; 2003 Feb; 145(2 Suppl):S3-17. PubMed ID: 12594447
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM, Crouch MA, Carroll NV, Oinonen MJ.
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [Abstract] [Full Text] [Related]

  • 9. Considerations on the efficacy and safety of levosimendan in ischemic heart failure.
    Nieminen MS, Sandell EP.
    Ital Heart J; 2003 May; 4 Suppl 2():39S-44S. PubMed ID: 14635369
    [Abstract] [Full Text] [Related]

  • 10. Pharmacologic therapy for acute heart failure.
    Tang WH.
    Cardiol Clin; 2007 Nov; 25(4):539-51; vi. PubMed ID: 18063158
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Levosimendan: beyond its simple inotropic effect in heart failure.
    Antoniades C, Tousoulis D, Koumallos N, Marinou K, Stefanadis C.
    Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacologic therapies for acutely decompensated heart failure.
    Fonarow GC.
    Rev Cardiovasc Med; 2002 May; 3 Suppl 4():S18-27. PubMed ID: 12439427
    [Abstract] [Full Text] [Related]

  • 16. Nesiritide for the treatment of decompensated heart failure.
    Wylie JV, Tsao L.
    Expert Rev Cardiovasc Ther; 2004 Nov; 2(6):803-13. PubMed ID: 15500426
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study.
    Burger AJ, Horton DP, LeJemtel T, Ghali JK, Torre G, Dennish G, Koren M, Dinerman J, Silver M, Cheng ML, Elkayam U, Prospective Randomized Evaluation of Cardiac Ectopy with Dobutamine or Natrecor Therapy.
    Am Heart J; 2002 Dec; 144(6):1102-8. PubMed ID: 12486437
    [Abstract] [Full Text] [Related]

  • 19. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
    Earl GL, Fitzpatrick JT.
    Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
    [Abstract] [Full Text] [Related]

  • 20. How mechanical circulatory support helps not to need it--new strategies in pediatric heart failure.
    Schweigmann U, Velik-Salchner C, Kilo J, Schermer E.
    Artif Organs; 2011 Nov; 35(11):1105-9. PubMed ID: 21954874
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.